Moaddel Ruin, Oliveira Regina V, Kimura Tomoko, Hyppolite Patrick, Juhaszova Magdalena, Xiao Yingxian, Kellar Kenneth J, Bernier Michel, Wainer Irving W
Gerontology Research Center, National Institutes on Aging, National Institutes of Health, Baltimore, Maryland 21224-6825, USA.
Anal Chem. 2008 Jan 1;80(1):48-54. doi: 10.1021/ac701943b. Epub 2007 Dec 7.
In this study, cellular membrane fragments from SH-EP1-pCEP4-halpha7 and alpha7 HEK-293 cell lines were used to synthesize cellular membrane affinity chromatography (CMAC) columns containing functional alpha7 nicotinic acetylcholine receptors, CMAC(alpha7 nAChR) columns. The synthesis of stable columns required the addition of cholesterol to the 2% cholate solubilization/immobilization (s/i) buffer and to the mobile phase. In addition, when membranes from the SH-EP1 cell line were used, l-alpha-phosphatidylserine and l-alpha-phosphatidylethanolamine also had to be added to the s/i buffer. A CMAC(alpha4beta2 nAChR) column was prepared using membrane fragments from a SH-EP1-pCEP4-halpha4beta2 cell line, and this process required the addition of l-alpha-phosphatidylserine and l-alpha-phosphatidylethanolamine to the s/i buffer, but not cholesterol. The s/i buffers from the three columns were compared with the s/i buffer utilized in the preparation of a CMAC(alpha4beta2 nAChR) column prepared using an alpha4beta2 HEK-293 cell line, which required no additions to the 2% cholate s/i buffer. The data demonstrate that both cell type and receptor type affect the protocol required to produce a stable CMAC column and that, at the current time, the development of an optimum immobilization protocol is an empirical process. The results are also consistent with the observation that the alpha7 nAChR is localized in lipid rafts in both of these cell lines and that the cholate detergent removed cholesterol from these microdomains.
在本研究中,使用来自SH-EP1-pCEP4-hα7和α7 HEK-293细胞系的细胞膜片段来合成含有功能性α7烟碱型乙酰胆碱受体的细胞膜亲和色谱(CMAC)柱,即CMAC(α7 nAChR)柱。合成稳定的柱需要在2%胆酸盐溶解/固定(s/i)缓冲液和流动相中添加胆固醇。此外,当使用SH-EP1细胞系的膜时,还必须向s/i缓冲液中添加l-α-磷脂酰丝氨酸和l-α-磷脂酰乙醇胺。使用来自SH-EP1-pCEP4-hα4β2细胞系的膜片段制备了CMAC(α4β2 nAChR)柱,此过程需要向s/i缓冲液中添加l-α-磷脂酰丝氨酸和l-α-磷脂酰乙醇胺,但不需要添加胆固醇。将这三根柱的s/i缓冲液与使用α4β2 HEK-293细胞系制备CMAC(α4β2 nAChR)柱时使用的s/i缓冲液进行比较,后者在2%胆酸盐s/i缓冲液中无需添加其他成分。数据表明,细胞类型和受体类型都会影响制备稳定CMAC柱所需的方案,并且目前,开发最佳固定方案是一个经验过程。这些结果也与以下观察结果一致:α7 nAChR在这两种细胞系的脂筏中均有定位,并且胆酸盐去污剂从这些微区中去除了胆固醇。